NEW YORK (GenomeWeb News) – Osmetech today said that its US distribution agreement with Thermo Fisher's Fisher Healthcare, which was signed earlier this year, has been terminated.

According to the UK-based molecular diagnostics firm, the firms mutually agreed to terminate the five-year contract, which was signed at the end of March.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.

GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.

Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.

A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.